7Baggers
 igms stock holds the spotlight as investors await fresh catalysts.  Ad-hoc-news.de Fri, 03 Jul 2026 11:11:42 GMT
 igm biosciences inc (igms) institutional confidence  TradingKey Wed, 17 Jun 2026 16:56:43 GMT
 igm biosciences inc (igms) valuation: pe, pb & fair value analysis  TradingKey Wed, 17 Jun 2026 16:55:17 GMT
 Right On-Target: Developing Safe and Selective Multispecific T-Cell Engagers  Technology Networks Thu, 23 Apr 2026 07:00:00 GMT
 published on: 2026-04-09 14:25:22  baoquankhu1.vn Thu, 09 Apr 2026 07:25:22 GMT
 published on: 2026-04-09 14:25:22  baoquankhu1.vn Wed, 08 Apr 2026 13:29:16 GMT
 if you invested $1,000 in igm biosciences, inc. (igms)  Stock Titan Sun, 22 Mar 2026 02:22:25 GMT
 igm biosciences, inc. (igms) competitors  Meyka Tue, 17 Mar 2026 20:59:33 GMT
 igms stock news today | earnings, events & price alerts  Intellectia AI Mon, 02 Mar 2026 14:02:46 GMT
 The IGM Biosciences Buyout: What Remains for Shareholders?  AD HOC NEWS Sun, 08 Feb 2026 08:00:00 GMT
 igm biosciences climbs on merger deal with concentra  MSN Sat, 17 Jan 2026 15:57:03 GMT
 published on: 2026-01-14 21:46:31  baoquankhu1.vn Wed, 14 Jan 2026 14:46:31 GMT

IGM Biosciences, Inc
(NASDAQ:IGMS) 

IGMS stock logo

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymp...

Founded: 1993
Full Time Employees: 103
CEO: Fred M. Schwarzer  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends